Next Article in Journal
The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
Previous Article in Journal
Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic
Open AccessCase Report

COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave

2nd Department of General Surgery, Medical University of Lublin, ul. Staszica 16, 20-400 Lublin, Poland
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2021, 28(2), 1348-1353; https://doi.org/10.3390/curroncol28020128
Received: 27 January 2021 / Revised: 12 March 2021 / Accepted: 22 March 2021 / Published: 27 March 2021
(This article belongs to the Section Gastrointestinal Oncology)
The coronavirus disease 2019 (COVID-19) pandemic has had a substantial impact on the provision of medical healthcare. Due to an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) transmission, elective surgical treatment has been suspended in many centers. The effects of COVID-19 in the early post-operative period after esophagectomy remains unknown. In this report, we present three cases of patients diagnosed with esophago-gastric junction cancer who were scheduled for elective esophagectomy with a curative intention during second wave of COVID-19 pandemic in a single high-volume tertiary center. Despite all available safety measures, one of the patients developed COVID-19 pneumonia on post-operative day two, leading to an impaired respiratory function and increased pleural fluid collection from the chest tube, resulting in a prolonged time of hospital stay. Finding a good balance between the COVID-19-related perioperative risks and consequences of delaying surgical treatment in patients diagnosed with esophago-gastric cancer is a challenge. In order to achieve the best possible outcome, care must be taken to ensure availability of necessary treatment options and to reduce the risk of SARS-Cov-2 transmission perioperatively. View Full-Text
Keywords: gastro-esophageal junction cancer; esophagectomy; COVID-19; pneumonia gastro-esophageal junction cancer; esophagectomy; COVID-19; pneumonia
Show Figures

Figure 1

MDPI and ACS Style

Nurczyk, K.; Chan, C.-E.; Nowak, N.; Skoczylas, T. COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave. Curr. Oncol. 2021, 28, 1348-1353. https://doi.org/10.3390/curroncol28020128

AMA Style

Nurczyk K, Chan C-E, Nowak N, Skoczylas T. COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave. Current Oncology. 2021; 28(2):1348-1353. https://doi.org/10.3390/curroncol28020128

Chicago/Turabian Style

Nurczyk, Kamil; Chan, Chia-En; Nowak, Norbert; Skoczylas, Tomasz. 2021. "COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave" Curr. Oncol. 28, no. 2: 1348-1353. https://doi.org/10.3390/curroncol28020128

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop